Atlas Trials

Meiji Seika Pharma Co., Ltd.

10 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Meiji Seika Pharma Co., Ltd.

RecordFirmDate
P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available Therapy for Adults With Infection Due to Carbapenem Resistant Enterobacterales (NCT05905055)Meiji Seika Pharma Co., Ltd.2023-09-22
Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects With Complicated Urinary Tract Infections or Acute Uncomplicated Pyelonephritis (NCT05887908)Meiji Seika Pharma Co., Ltd.2023-05-23

Track Meiji Seika Pharma Co., Ltd. automatically

Every clearance here is in the API, with alerts when new ones post.